Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Aparna Parikh
9
Mins
April 2024
Once I got into fellowship, and started to see a lot of GI patients, I found a tremendous affinity towards this patient population…
Read more
26th January 2016
Diagnosis and Treatment of Bladder Cancer: From Established Paradigms to Recent Advances and New Perspectives
Bladder cancer (BC) certainly represents a challenging disease for the patient, given the significant impact on health-related quality of life, and for…
26th January 2016
Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
Pancreatic cancer is the most common lethal cancer, with annual incidence and mortality rates being approximately equal.
19th November 2015
The debate between prevention and cure of breast cancer by Prof. Rob Coleman
Prof. Rob Coleman gives an overview of the session “This house believes we should stop focussing on the causes of breast cancer and get on with…
12th November 2015
Intelligent Application of Breast Cancer Trials Data in the Clinic
This meeting commenced with a talk from Prof Loibl on neoadjuvant and adjuvant strategies for HER2positive (human epidermal growth factor receptor…)
12th November 2015
Incorporating PARP Inhibition in Cancer Therapy: Key Questions, Expert Answers
This engaging symposium focussed on the rationale and current evidence supporting the role for poly(adenosine diphosphate-ribose) polymerase (PARP)…
12th November 2015
Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)
The METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) was reported by Prof Choueiri at the European Cancer Congress…
12th November 2015
Current and Future Developments in the Treatment of CD30+ Lymphomas
CD30 is a cell membrane protein expressed on the surface of a range of lymphomas, which has important diagnostic, pathogenic, and prognostic roles.
2
Mins
4th June 2015
The Last Frontier, Men’s Health
The 21st century is well upon us, and the scientific and health landscape is rapidly changing, yet there are still new horizons to conquer.
Loading posts...
« Previous
1
…
19
20
21
22
23
…
26
Next »